Sage Therapeutics Could Still Become A Leader In Neurology By: Benzinga via Benzinga September 15, 2017 at 14:06 PM EDT RBC Capital Markets said in a Thursday note it believes SAGE Therapeutics Inc (NASDAQ: SAGE) can still emerge from near-term catalysts ... Read More >> Related Stocks: Sage Therapeutic Com